Literature DB >> 8360731

The use of moderate therapeutic hypothermia for patients with severe head injuries: a preliminary report.

D W Marion1, W D Obrist, P M Carlier, L E Penrod, J M Darby.   

Abstract

Animal research suggests that moderate therapeutic hypothermia may improve outcome after a severe head injury, but its efficacy has not been established in humans. The authors randomly assigned 40 consecutively treated patients with a severe closed head injury (Glasgow Coma Scale score 3 to 7) to either a hypothermia or a normothermia group. Using cooling blankets and cold saline gastric lavage, patients in the hypothermia group were cooled to 32 degrees to 33 degrees C (brain temperature) within a mean of 10 hours after injury, maintained at that temperature for 24 hours, and rewarmed to 37 degrees to 38 degrees C over 12 hours. Patients in the normothermia group were maintained at 37 degrees to 38 degrees C during this time. Deep-brain temperatures were monitored directly and used for all temperature determinations. Intracranial pressure (ICP), cerebral blood flow (CBF), and cerebral metabolic rate for oxygen (CMRO2) were measured serially for all patients. Hypothermia significantly reduced ICP (40%) and CBF (26%) during the cooling period, and neither parameter showed a significant rebound increase after patients were rewarmed. Compared to the normothermia group, the mean CMRO2 in the hypothermia group was lower during cooling and higher 5 days after injury. Three months after injury, 12 of the 20 patients in the hypothermia group had moderate, mild, or no disabilities; eight of the 20 patients in the normothermia group had improved to the same degree. Both groups had a similar incidence of systemic complications, including cardiac arrhythmias, coagulopathies, and pulmonary complications. It is concluded that therapeutic moderate hypothermia is safe and has sustained favorable effects on acute derangements of cerebral physiology and metabolism caused by severe closed head injury. The trend toward better outcome with hypothermia may indicate that its beneficial physiological and metabolic effects limit secondary brain injury.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8360731     DOI: 10.3171/jns.1993.79.3.0354

Source DB:  PubMed          Journal:  J Neurosurg        ISSN: 0022-3085            Impact factor:   5.115


  45 in total

Review 1.  Osmotic therapy: fact and fiction.

Authors:  Michael N Diringer; Allyson R Zazulia
Journal:  Neurocrit Care       Date:  2004       Impact factor: 3.210

2.  Posthypoxic cooling of neonatal rats provides protection against brain injury.

Authors:  M Thoresen; R Bågenholm; E M Løberg; F Apricena; I Kjellmer
Journal:  Arch Dis Child Fetal Neonatal Ed       Date:  1996-01       Impact factor: 5.747

Review 3.  Hypothermia following pediatric traumatic brain injury.

Authors:  P David Adelson
Journal:  J Neurotrauma       Date:  2009-03       Impact factor: 5.269

Review 4.  New concepts in treatment of pediatric traumatic brain injury.

Authors:  Jimmy W Huh; Ramesh Raghupathi
Journal:  Anesthesiol Clin       Date:  2009-06

Review 5.  Trends in neuroanaesthesia.

Authors:  J E Cottrell
Journal:  Can J Anaesth       Date:  1996-05       Impact factor: 5.063

6.  Therapeutic Hypothermia Reduces Intracranial Pressure and Partial Brain Oxygen Tension in Patients with Severe Traumatic Brain Injury: Preliminary Data from the Eurotherm3235 Trial.

Authors:  Liam M C Flynn; Jonathan Rhodes; Peter J D Andrews
Journal:  Ther Hypothermia Temp Manag       Date:  2015-05-19       Impact factor: 1.286

7.  The anticonvulant effect of cooling in comparison to α-lipoic acid: a neurochemical study.

Authors:  Yasser A Khadrawy; Heba S Aboulezz; Nawal A Ahmed; Haitham S Mohammed
Journal:  Neurochem Res       Date:  2013-02-07       Impact factor: 3.996

8.  A prospective, observational clinical trial of fever reduction to reduce systemic oxygen consumption in the setting of acute brain injury.

Authors:  J Steven Hata; Constance R Shelsky; Bradley J Hindman; Thomas C Smith; Jonathan S Simmons; Michael M Todd
Journal:  Neurocrit Care       Date:  2008       Impact factor: 3.210

9.  Temperature response to severe head injury and the effect on body energy expenditure and cerebral oxygen consumption.

Authors:  D S Matthews; R E Bullock; J N Matthews; A Aynsley-Green; J A Eyre
Journal:  Arch Dis Child       Date:  1995-06       Impact factor: 3.791

10.  Management of hepatic encephalopathy.

Authors:  Jennifer A Frontera
Journal:  Curr Treat Options Neurol       Date:  2014-06       Impact factor: 3.598

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.